Diagnosis, Management & Treatment of Progressive Neurological Disease

National Tay-Sachs & Allied Diseases Association, Inc (NTSAD) and Brigham & Women’s Hospital are pleased to offer a CME Conference, Diagnosis, Management & Treatment of Progressive Neurological Disease from Infancy to Adult using Tay-Sachs Disease as a Model. This CME Conference for specialized clinicians and general practitioners will be held on Monday, September 21st from 1 – 5PM at the Joseph B. Martin Conference Center at Harvard Medical School. It will also be available by Webcast.

This program is designed for neurologists, general practitioners, pediatricians, palliative and complex care pediatricians and physicians, psychologists, physical, occupational and speech therapists, nurses and others interested in improving differential diagnosis, clinical care and understanding of the family perspective.

The program consists of leading lysosomal clinicians discussing case studies along the continuum of severity; several include the family perspective. Topics include road to diagnosis, critical moments in care and providing compassionate symptom management.

Program Objectives:
• Improved differential diagnosis of neurodegenerative disease
• Improved clinical care of progressive neurological diseases along the spectrum from acute to chronic
• Improved understanding of the family perspective, their road to diagnosis & providing family centered-care
• Secondary goal: improved knowledge of neurodegenerative lysosomal disease

Please email Kim@ntsad.org for further information.

Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians. Harvard Medical School designates this educational activity for a maximum of 4 AMA PRA Category 1 credits. TM.